In brief: Methotrexate and liver fibrosis

Patients with type-2 diabetes who are receiving methotrexate for psoriasis have an increased risk of severe liver fibrosis, according to the results of a study in Sweden. Researchers reviewed 169 liver biopsies from 71 patients with psoriasis being treated with methotrexate. Of the 26 patients who had one or more of type-2 diabetes, overweight, alcohol over-consumption, or chronic hepatitis B or C, 25 developed fibrosis. Risk of fibrosis for psoriasis patients with one of these other conditions was elevated even when lower cumulative doses of methotrexate were used to treat them.
Rosenberg P, Urwitz H, Johannesson A et al. J Hepatol 2007;46:1111-18.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

MIMS Product Slides

Product overviews prepared by the MIMS team, in a handy slide format.

Click here

Slides are initiated, funded & reviewed by the companies specified.

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more